MoneyWorks4Me

Themis Medicare informs about analyst meet

22 Sep 2022 Evaluate

Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Listing Regulations’) read with part A of Schedule III of the Listing Regulations, Themis Medicare has informed that the management of the Company will do an online meeting with Analysts/Investors on Monday, 26thSeptember 2022; the details of the same are enclosed. The schedule of the aforesaid meetings is subject to change and the changes may happen due to exigencies on the part of Fund / Broking House / Company. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company: www.themismedicare.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..